Interview Notes: Foreign monks are good at chanting sutras, and their own Zen language is also listened.
Release time:
2021-09-01
pharmaceutical company said after observing and studying on # February 20 that the morning meeting of the cable company made them feel a lot and benefited a lot.
As the saying goes, "Foreign monks are good at chanting sutras". When an enterprise wants to hold an activity or skill training, the first reaction is to invite an outside company or expert to handle it. This phenomenon is very common. "Foreign monks" are relatively unfamiliar to everyone. The distance brings a sense of mystery and freshness, and the scriptures they read can't help but rise. Because "their own monks" are too familiar and too common, they are easy to become psychological blind spots when selecting candidates.
Appropriate introduction of external resources can indeed help companies broaden their horizons and contact new things. It should be noted that the experience of "foreign monks" is extracted and summarized in their environment, and may not be completely applicable to us. When learning and implementing, we must screen and make changes. People in the enterprise know more about their actual situation and sometimes can give more direct and effective solutions. Jianfeng Group is a big family. When looking for external solutions, each unit may wish to ask its brothers if they have encountered similar situations and how they solved them.
In the eyes of some people, the branches of the group's subsidiaries are in many industries such as cement, medicine, health products, trade and logistics. They are separated from each other. The industries are different, the problems they face are different, and there is no mutual reference value. However, from the perspective of enterprise management, the perspective of looking at the problem and the idea of analyzing the problem are applicable. There are many opportunities for brother units to communicate with each other, it is convenient to organize, and the cost is lower. If there are conditions for more in-depth exchanges and long-term discussions, you can observe the practice of new systems and new ideas in a longer period of time. Effect, better digest the learning results.
2021is the first year of the "14th Five-Year Plan". With the changing international situation, the macroeconomic pattern and trend will usher in great changes. In the face of market changes and responding to market competition, enterprises, as market entities that are responsible for their own profits and losses, in addition to careful study and accurate judgment of market trends, it is the key to strengthen self-cultivation and exercise "internal forces. Zhang Ci, general manager of
Cable Company, said that the group company has a good way to learn from each other, and can fully explore and show the strengths and bright spots of each unit for reference by brother enterprises. Cable companies will also go to pharmaceutical companies and other brother units to learn and observe in the future. It can be seen that from the perspective of internal resource sharing, the group company may wish to match more and organize experience exchange activities, so that the good experience of subordinate enterprises can be promoted and utilized in a timely manner. When each unit is working hard to build a learning organization, train a good talent team, and improve its comprehensive competitiveness, it is also necessary to summarize and sort out its good methods and good experience in this process in a timely manner, and communicate with brother units. At that time, it is not only "learning from experience", but also "sending treasure".
(Chen Shengmu)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page